Cowen And Company »

Avepoint shares owned by Cowen And Company

Quarter-by-quarter ownership of Avepoint (AVPTW) shares owned by Cowen And Company from 13F filings

Historical chart of Cowen And Company investment in Avepoint

Tip: Access up to 7 years of quarterly data

All positions including Avepoint held by Cowen And Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avepoint by Cowen And Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $67k 71k 0.95

More positions owned by Cowen And Company

NVIDIA Corporation (NVDA)
Coinbase Global Com Cl A (COIN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Avidity Biosciences Ord (RNA)
Meta Platforms Cl A (META)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ptc Therapeutics I (PTCT)
Tarsus Pharmaceuticals (TARS)
Quanta Services (PWR)
Establishment Labs Holdings Ord (ESTA)
Stoke Therapeutics (STOK)
Protagonist Therapeutics (PTGX)
Apple (AAPL)
Fulcrum Therapeutics (FULC)
Sumitomo Mitsui Finl Group I Sponsored Adr (SMFG)

View all positions for Cowen And Company

Top funds holding Avepoint

LMR Partners
Ionic Capital Management
Aristeia Capital
Weiss Asset Management LP[1
CSS
D. E. Shaw & Co
Walleye Trading Advisors
Marshall Wace
Saba Capital Management
Millennium Management
Two Sigma Investments
Privium Fund Management B.V.
Cowen And Company
Wolverine Asset Management
William Blair $ Company

View all funds holding Avepoint